Latin America Investor Daily
SEE OTHER BRANDS

Get your fresh news on finance and banking in Latin America

Latin America Investor Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Investor Daily.

Press releases published on May 14, 2025

IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights

IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights

Primary endpoint of pivotal Phase 3 trial (IOB-013/KN-D18) of lead investigational therapeutic cancer vaccine in patients with advanced melanoma still expected to readout in third quarter of 2025 Data presented at recent congresses reinforces the potential …

Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing

Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing

IRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the first and only U.S. Food and Drug Administration (FDA) cleared direct-to-consumer (DTC) test for celiac disease genetics, today announced a commercial …

Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights

Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights

Actively enrolling nAMD patients in a Phase 1 trial of TH103, a novel, differentiated anti-VEGF agent engineered to potentially provide longer-lasting and increased anti-VEGF activity to treat neovascular and exudative diseases of the retina; initial …

Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced financial …

Redfin and Magnite Join Forces to Give Advertisers Priority Access to Audience Targeting Across the Homebuying Journey

Redfin and Magnite Join Forces to Give Advertisers Priority Access to Audience Targeting Across the Homebuying Journey

NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) --  Redfin (NASDAQ: RDFN), the technology-powered real estate brokerage, has selected Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, as its preferred SSP to power data-driven deals. …

Project EverGreen and ScottsMiracle-Gro Expand Green Spaces at Heat-stressed Phoenix Park

Project EverGreen and ScottsMiracle-Gro Expand Green Spaces at Heat-stressed Phoenix Park

PHOENIX, May 14, 2025 (GLOBE NEWSWIRE) -- Project EverGreen and ScottsMiracle-Gro have launched the second phase of a major renovation at Barrios Unidos Park that includes planting of trees, grass and native plants. This transformative effort, part of …

Gateless Integrates with Fannie Mae’s Income Calculator to Enhance Self-Employment Income Analysis

Gateless Integrates with Fannie Mae’s Income Calculator to Enhance Self-Employment Income Analysis

CHICAGO, May 14, 2025 (GLOBE NEWSWIRE) -- Gateless, a leading innovator in mortgage automation technology, today announced its integration with Fannie Mae’s Income Calculator. This strategic collaboration enables mortgage lenders to quickly and accurately …

Avis Budget Group Announces Intention to Offer $500 Million of Senior Notes

Avis Budget Group Announces Intention to Offer $500 Million of Senior Notes

PARSIPPANY, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”), intend, …

Glass House Brands and LEEF Announce MSA for The Leaf El Paseo Dispensary and Off-Take Agreement

Glass House Brands and LEEF Announce MSA for The Leaf El Paseo Dispensary and Off-Take Agreement

LONG BEACH, Calif. and TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF) – one of the fastest-growing, vertically integrated cannabis …

Arabsat selects Telesat Lightspeed Low Earth Orbit (LEO) services for its multi-orbit connectivity portfolio

Arabsat selects Telesat Lightspeed Low Earth Orbit (LEO) services for its multi-orbit connectivity portfolio

DUBAI, United Arab Emirates, May 14, 2025 (GLOBE NEWSWIRE) -- Telesat (NASDAQ and TSX: TSAT), one of the world’s largest and most innovative satellite operators, and Arab Satellite Communications Organization (Arabsat), the top satellite service provider …

Pony AI Inc. Announces Voluntary Extended Lock-Ups by Founders

Pony AI Inc. Announces Voluntary Extended Lock-Ups by Founders

SHANGHAI, China, May 14, 2025 (GLOBE NEWSWIRE) -- Pony AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in achieving large-scale commercialization of autonomous mobility, today announced that Dr. Jun Peng, Chairman of the Board, Co- …

Bombardier Announces Launch of US$500 million New Issuance of Senior Notes due 2033 to retire US$500 million of its Senior Notes due 2027

Bombardier Announces Launch of US$500 million New Issuance of Senior Notes due 2033 to retire US$500 million of its Senior Notes due 2027

MONTRÉAL, May 14, 2025 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has launched an offering of US$500 million aggregate principal amount of new Senior Notes due 2033 (the “New Notes”). Bombardier intends to use the proceeds …

Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights

Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights

- Interim data from ENERGY 3 trial highlight INZ-701’s potential to modify disease course in ENPP1 Deficiency, with sustained phosphate increases and favorable safety and immunogenicity profile to date - - ENERGY 3 trial on track for topline data in first …

PussFi Launches $PUSS: Turning Memes into Real-Utility Tokens!

PussFi Launches $PUSS: Turning Memes into Real-Utility Tokens!

DUBAI, United Arab Emirates, May 14, 2025 (GLOBE NEWSWIRE) -- PussFi has officially launched $PUSS, the first-ever meme-tility token (a meme coin with real-world utility), on Steemit, a decentralized social media platform. Built on the Tron blockchain, $ …

Calian Reports Results for the Second Quarter

Calian Reports Results for the Second Quarter

(All amounts in release are in Canadian dollars) OTTAWA, Ontario, May 14, 2025 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (TSX:CGY), a mission critical solutions company, with a focus on defence, space, healthcare and strategic growth markets, today released …

Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

Resolution of CRL Manufacturing issues in progress - Type A meeting requested No clinical safety or efficacy concerns raised by FDA MONTREAL and CHARLOTTE, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported …

KP Tissue declares a Quarterly Dividend of $0.18 per Common Share

KP Tissue declares a Quarterly Dividend of $0.18 per Common Share

NOT FOR DISTRIBUTION IN THE U.S.A. OR OVER U.S. WIRE SERVICES MISSISSAUGA, Ontario, May 14, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) announced today that the Board of Directors has declared a quarterly dividend of $0.18 per common share, …

Mesa Air Group Reports Fourth Quarter and Fiscal Full-Year 2024 Results

Mesa Air Group Reports Fourth Quarter and Fiscal Full-Year 2024 Results

PHOENIX, May 14, 2025 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today reported fourth quarter and fiscal full-year 2024 financial and operating results. Fourth Quarter Fiscal 2024 Update: Total operating revenues of …

PolyPid Provides Corporate Update and Reports First Quarter 2025 Financial Results

PolyPid Provides Corporate Update and Reports First Quarter 2025 Financial Results

PolyPid Successfully Completed Enrollment in Phase 3 SHIELD II Trial of D-PLEX100, with Top-Line Results Anticipated in Current Quarter Company Continues to Advance Regulatory Submission Preparations, Commercial Launch Preparations and Partnering …

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2025 Financial Results

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2025 Financial Results

Reported positive initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 demonstrating dose-dependent decreases in blood LDL-C and PCSK9 Mean reduction in LDL-C of 53%, with a maximum reduction of 69%, observed after a single infusion of VERVE- …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service